Tuberculosis in people with HIV.
Bellamy
Richard
R
Department of Infection and Travel Medicine, James Cook University Hospital, Middlesbrough, UK.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017828:Rifabutin / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D017828:Rifabutin; D013828:Thioacetazone